ArticleNature communications2024

Split-design approach enhances the therapeutic efficacy of ligand-based CAR-T cells against multiple B-cell malignancies.

Shuhong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.